Which one is better? The answer might surprise you…
We just completed a deep-dive research report comparing two of the most powerful metabolic peptides in clinical development:
🔹 Tirzepatide (Zepbound / Mounjaro)
🔹 Retatrutide (LY3437943) – the triple agonist making headlines for unprecedented fat loss
Here's what we found:
✅ Tirzepatide hits hard on hunger — it's like putting a lock on the fridge
✅ Retatrutide turns up your metabolism — like raising your internal thermostat to burn more fat
✅ Retatrutide is not just Tirzepatide + glucagon — it has a completely different receptor balance
✅ Some users lose up to 24.2% of their body weight in under 48 weeks (more than any GLP-1 drug so far)
✅ Appetite suppression is more variable — meaning it requires more structure, not less
“Tirzepatide helps you eat less.Retatrutide helps you burn more.” 🔥
We broke it all down in plain English — from mechanisms to trial data to real-world strategy.
📘 This is also available in the class room